Cohere Acquires Reliant AI to Expand Sovereign Enterprise AI for Global Biopharma ... - HPC Wire
PushButton AI Team ·
Cohere Acquires Reliant AI to Expand Sovereign Enterprise AI for Global Biopharma ... - HPC Wire
Big AI companies are getting more specialized. That's actually good news for you — and here's why most people miss it.
You bought that AI tool. Nobody used it. $200/month quietly bleeding out while t
Big AI companies are getting more specialized. That's actually good news for you — and here's why most people miss it.
You bought that AI tool. Nobody used it. $200/month quietly bleeding out while the team went back to their old habits. You're not alone, and it wasn't stupidity. It was the wrong tool sold with the wrong promise.
Here's what this week's news actually signals: even enterprise-level AI companies are now narrowing their focus. Cohere just acquired a firm specifically to serve pharmaceutical and healthcare businesses. Not everyone. One industry. Deep expertise in one problem.
That's the model that works. Not one AI to rule everything — but one AI built for one specific job in your specific business. The broader the promise, the thinner the results.
The shift happening at the top filters down. Vendors are being forced to get specific. That means you now have more power to ask: "What exact problem does this solve, and can you show me proof it worked for a business like mine?" If they can't answer that clearly, walk away.
What's the one workflow in your business that costs you the most time every single week? Drop it below — I'll tell you honestly whether AI is the right tool for it.
